Psilocybin clinical trials at UC Cancer
2 research studies open to eligible people
Showing trials for
Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease
open to eligible people ages 40-75
The purpose of this study is to determine the safety, tolerability, and feasibility of psilocybin therapy for depression and anxiety in people with Parkinson's disease.
at UCSF
Psilocybin Therapy for Depression in Bipolar II Disorder
open to eligible people ages 30-65
The purpose of this study is to determine the safety, tolerability, and feasibility of psilocybin therapy in people with Bipolar II Disorder.
at UCSF
Our lead scientists for Psilocybin research studies include Joshua Woolley, MD/PhD.